NCT02902913View on ClinicalTrials.gov

Impact of Extra Virgin Olive Oil Oleocanthal Content on Platelet Reactivity

NACompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

September 30, 2015

Study Completion Date

September 30, 2015

Conditions
Cardiovascular Diseases
Interventions
OTHER

D2i2

Oleocanthal provided in a 2:1 ratio compared to oleacein

OTHER

D2i0.5

Oleocanthal provided in a 1:2 ratio compared to oleacein

OTHER

D2i0

No oleocanthal and no oleacein

DRUG

Ibuprofen

400 mg of Ibuprofen

All Listed Sponsors
collaborator

USDA, Western Human Nutrition Research Center

FED

lead

University of California, Davis

OTHER

NCT02902913 - Impact of Extra Virgin Olive Oil Oleocanthal Content on Platelet Reactivity | Biotech Hunter | Biotech Hunter